BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 28692661)

  • 21. Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy.
    Jiang H; Hegde S; Knolhoff BL; Zhu Y; Herndon JM; Meyer MA; Nywening TM; Hawkins WG; Shapiro IM; Weaver DT; Pachter JA; Wang-Gillam A; DeNardo DG
    Nat Med; 2016 Aug; 22(8):851-60. PubMed ID: 27376576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Activation of β1-integrin by Type I Collagen Coupling with the Hedgehog Pathway Promotes the Epithelial-Mesenchymal Transition in Pancreatic Cancer.
    Duan W; Ma J; Ma Q; Xu Q; Lei J; Han L; Li X; Wang Z; Wu Z; Lv S; Ma Z; Liu M; Wang F; Wu E
    Curr Cancer Drug Targets; 2014; 14(5):446-57. PubMed ID: 24720337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. δ-Tocotrienol, a natural form of vitamin E, inhibits pancreatic cancer stem-like cells and prevents pancreatic cancer metastasis.
    Husain K; Centeno BA; Coppola D; Trevino J; Sebti SM; Malafa MP
    Oncotarget; 2017 May; 8(19):31554-31567. PubMed ID: 28404939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma.
    Kanteti R; Mirzapoiazova T; Riehm JJ; Dhanasingh I; Mambetsariev B; Wang J; Kulkarni P; Kaushik G; Seshacharyulu P; Ponnusamy MP; Kindler HL; Nasser MW; Batra SK; Salgia R
    Cancer Biol Ther; 2018 Apr; 19(4):316-327. PubMed ID: 29303405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ADAM8 as a drug target in pancreatic cancer.
    Schlomann U; Koller G; Conrad C; Ferdous T; Golfi P; Garcia AM; Höfling S; Parsons M; Costa P; Soper R; Bossard M; Hagemann T; Roshani R; Sewald N; Ketchem RR; Moss ML; Rasmussen FH; Miller MA; Lauffenburger DA; Tuveson DA; Nimsky C; Bartsch JW
    Nat Commun; 2015 Jan; 6():6175. PubMed ID: 25629724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC.
    Cao XY; Zhang XX; Yang MW; Hu LP; Jiang SH; Tian GA; Zhu LL; Li Q; Sun YW; Zhang ZG
    Biochem Biophys Res Commun; 2018 May; 499(3):584-593. PubMed ID: 29621546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marker-free lineage tracing reveals an environment-instructed clonogenic hierarchy in pancreatic cancer.
    Lodestijn SC; Miedema DM; Lenos KJ; Nijman LE; Belt SC; El Makrini K; Lecca MC; Waasdorp C; van den Bosch T; Bijlsma MF; Vermeulen L
    Cell Rep; 2021 Oct; 37(3):109852. PubMed ID: 34686335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells.
    Verma A; Guha S; Wang H; Fok JY; Koul D; Abbruzzese J; Mehta K
    Clin Cancer Res; 2008 Apr; 14(7):1997-2005. PubMed ID: 18381937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidimensional screening of pancreatic cancer spheroids reveals vulnerabilities in mitotic and cell-matrix adhesion signaling that associate with metastatic progression and decreased patient survival.
    Aquino AF; Runa F; Shoma JF; Todd A; Wallace M; de Barros NR; Kelber JA
    Biochem Biophys Res Commun; 2024 Apr; 703():149575. PubMed ID: 38382357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport.
    Nagarajan A; Dogra SK; Sun L; Gandotra N; Ho T; Cai G; Cline G; Kumar P; Cowles RA; Wajapeyee N
    Mol Cell; 2017 Aug; 67(4):685-701.e6. PubMed ID: 28803777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrin-mediated differentiation of a pancreatic carcinoma cell line is independent of FAK or MAPK activation levels.
    Stagge V; Seufferlein T; Duerschmied D; Menke A; Adler G; Beil M
    Pancreas; 2001 Oct; 23(3):236-45. PubMed ID: 11590318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth.
    Kurenova E; Liao J; He DH; Hunt D; Yemma M; Bshara W; Seshadri M; Cance WG
    Oncotarget; 2013 Oct; 4(10):1632-46. PubMed ID: 24142503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Collagen regulation of let-7 in pancreatic cancer involves TGF-β1-mediated membrane type 1-matrix metalloproteinase expression.
    Dangi-Garimella S; Strouch MJ; Grippo PJ; Bentrem DJ; Munshi HG
    Oncogene; 2011 Feb; 30(8):1002-8. PubMed ID: 21057545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phytochemicals, withaferin A and carnosol, overcome pancreatic cancer stem cells as c-Met inhibitors.
    Aliebrahimi S; Kouhsari SM; Arab SS; Shadboorestan A; Ostad SN
    Biomed Pharmacother; 2018 Oct; 106():1527-1536. PubMed ID: 30119228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells.
    Dalla Pozza E; Dando I; Biondani G; Brandi J; Costanzo C; Zoratti E; Fassan M; Boschi F; Melisi D; Cecconi D; Scupoli MT; Scarpa A; Palmieri M
    Int J Oncol; 2015 Mar; 46(3):1099-108. PubMed ID: 25502497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and DDX3.
    Karmakar S; Rauth S; Nallasamy P; Perumal N; Nimmakayala RK; Leon F; Gupta R; Barkeer S; Venkata RC; Raman V; Rachagani S; Ponnusamy MP; Batra SK
    Gastroenterology; 2020 Nov; 159(5):1898-1915.e6. PubMed ID: 32781084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer.
    Canel M; Sławińska AD; Lonergan DW; Kallor AA; Upstill-Goddard R; Davidson C; von Kriegsheim A; Biankin AV; Byron A; Alfaro J; Serrels A
    Gut; 2023 Dec; 73(1):131-155. PubMed ID: 36977556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The microRNA-200/Zeb1 axis regulates ECM-dependent β1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKL.
    Ungewiss C; Rizvi ZH; Roybal JD; Peng DH; Gold KA; Shin DH; Creighton CJ; Gibbons DL
    Sci Rep; 2016 Jan; 6():18652. PubMed ID: 26728244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of uPAR retards radiation-induced invasion and migration mediated by integrin β1/FAK signaling in medulloblastoma.
    Nalla AK; Asuthkar S; Bhoopathi P; Gujrati M; Dinh DH; Rao JS
    PLoS One; 2010 Sep; 5(9):e13006. PubMed ID: 20886051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transforming growth factor beta-induced, an extracellular matrix interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration.
    Costanza B; Rademaker G; Tiamiou A; De Tullio P; Leenders J; Blomme A; Bellier J; Bianchi E; Turtoi A; Delvenne P; Bellahcène A; Peulen O; Castronovo V
    Int J Cancer; 2019 Sep; 145(6):1570-1584. PubMed ID: 30834519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.